Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P McGuire

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Current status of taxane and platinum-based chemotherapy in ovarian cancerWilliam P McGuire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
CA-125 and early ovarian cancer: does this help the clinician or further muddy the water?William P McGuire
Journal of the National Cancer Institute|August 3, 2006
Is it time for some new approaches for treating advanced ovarian cancer?William P McGuire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2007
Ovarian cancer and the battle of the specialistsWilliam P McGuire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2004
Perioperative morbidity and the rush to chemotherapyWilliam P McGuire
Journal of the National Cancer Institute|October 13, 2010
Another confirmation of the inactivity of topotecan in ovarian cancerWilliam P McGuire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Reply to T.j. Herzog et AlWilliam P McGuire
Oncology (Williston Park, N.Y.)|August 6, 2013
HE4--another marker for gynecologic cancers: do we really need one?William P McGuire
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Recurrent ovarian cancerMohan K Tummala, William P McGuire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Ovarian cancer and antiangiogenic therapy: caveat emptorKate E Oliver, William P McGuire
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Current status of taxane and platinum-based chemotherapy in ovarian cancerWilliam P McGuire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
CA-125 and early ovarian cancer: does this help the clinician or further muddy the water?William P McGuire
Journal of the National Cancer Institute|August 3, 2006
Is it time for some new approaches for treating advanced ovarian cancer?William P McGuire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2007
Ovarian cancer and the battle of the specialistsWilliam P McGuire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2004
Perioperative morbidity and the rush to chemotherapyWilliam P McGuire
Journal of the National Cancer Institute|October 13, 2010
Another confirmation of the inactivity of topotecan in ovarian cancerWilliam P McGuire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Reply to T.j. Herzog et AlWilliam P McGuire
Oncology (Williston Park, N.Y.)|August 6, 2013
HE4--another marker for gynecologic cancers: do we really need one?William P McGuire
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Recurrent ovarian cancerMohan K Tummala, William P McGuire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Ovarian cancer and antiangiogenic therapy: caveat emptorKate E Oliver, William P McGuire
Pageof 5